Search
Akari Therapeutics PLC
AKTXAdd to Watchlist
10.410USD
+0.160+1.56%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
11.92MMarket Cap
LossP/E TTM
Akari Therapeutics PLC Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.52
99.22%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its current assets were 5.46M, with a year-on-year change of 85.03.
What are the total assets of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its total assets of Akari Therapeutics PLC were 47.89M, with a year-on-year change of -5.28.
What are the total liabilities of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its total liabilities of Akari Therapeutics PLC were 19.56M, with a year-on-year change of -30.95.
What is the total equity of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its total equity of Akari Therapeutics PLC was 28.33M, with a year-on-year change of 27.44.
What is the net financing of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its net financing of Akari Therapeutics PLC was 13.17M, with a year-on-year change of 19.87.
What is the Earnings Per Share (EPS) of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -0.52, with a year-on-year change of 99.22.
What is the debt-to-asset ratio of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its debt-to-asset ratio was 1.57, with a year-on-year change of -75.58.
What is the Return on Equity (ROE) of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its Return on Equity (ROE) was -68.43, with a year-on-year change of 61.97.
What is the Return on Assets (ROA) of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its Return on Assets (ROA) was -35.14, with a year-on-year change of 51.25.
What is the operating profit of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its operating profit was -17.27M, with a year-on-year change of 3.65.